CTC (Chicago Trading Company)
MRNA icon

CTC (Chicago Trading Company)’s Moderna MRNA Stock Holding History

CTC (Chicago Trading Company)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-43,200
Closed -$1.8M – 229
2024
Q4 		$1.8M Buy
43,200
+42,623
+7,387% +$2.04M ﹤0.01% 217
2024
Q3 		$3.86M Sell
577
-748
-56% -$68.7K ﹤0.01% 197
2024
Q2 		$15.7M Sell
1,325
-1,254
-49% -$159K 0.01% 161
2024
Q1 		$27.5M Sell
2,579
-2,575
-50% -$260K 0.01% 150
2023
Q4 		$51.3M Buy
5,154
+1,783
+53% +$150K 0.03% 134
2023
Q3 		$34.8M Sell
3,371
-1,424
-30% -$159K 0.02% 145
2023
Q2 		$58.3M Sell
4,795
-475
-9% -$63.4K 0.03% 129
2023
Q1 		$77.7M Buy
5,270
+4,678
+790% +$772K 0.05% 99
2022
Q4 		$106K Sell
592
-76
-11% -$12.4K 0.08% 59
2022
Q3 		$78.9K Sell
668
-281
-30% -$42.6K 0.05% 92
2022
Q2 		$135K Sell
949
-11,643
-92% -$1.66M 0.08% 52
2022
Q1 		$217K Buy
12,592
+12,007
+2,052% +$2.02M 0.1% 53
2021
Q4 		$148K Buy
585
+118
+25% +$34.5K 0.06% 58
2021
Q3 		$180K Buy
+467
New +$172K 0.09% 52

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CTC (Chicago Trading Company)'s MRNA Position: Q1 2025 in Review

CTC (Chicago Trading Company) sold out of Moderna (MRNA) in Q1 2025, closing a stake of 24,266 shares — an estimated $1.01M sold.

CTC (Chicago Trading Company) first reported a position in MRNA in Q3 2021 and held it in 8 quarters. The position peaked at $9.52M in Q2 2023. 696 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • CTC (Chicago Trading Company) reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 24,266 Moderna shares in Q1 2025, an estimated $1.01M.
  • CTC (Chicago Trading Company) first reported a position in Moderna in Q3 2021 and held it in 8 quarters.
  • CTC (Chicago Trading Company)'s Moderna position peaked at $9.52M in Q2 2023.
  • 696 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on CTC (Chicago Trading Company)'s 13F filing for Q1 2025, filed 16 May 2025.